Cipro - News Articles

Technology news | Moneyweb


Valor IT took legal action to force the department to uphold the contract to complete an overhaul of Cipro's legacy IT systems. The Department of Trade and ...
UroToday - Please Login - Increased human pathogenic potential of Escherichia coli from polymicrobial urinary tract infections in comparison to isolates from monomicrobial culture samples - Abstract


from elderly patients, and of resistance to front line antibiotics, with potentially increased levels of resistance to ciprofloxacin and trimethoprim. ...
UroToday - Please Login - SUNA FALL 2010 - Genitourinary infections - Session Highlights


A three-day course of Bactrim, Macrobid, Ciprofloxacin, or Floxin is the recommended treatment for an uncomplicated UTI. However, Ms. Brassil suggests for a ...
Court saves hijacked firm - Times LIVE


The Louws' lawyer, Elijah Ramonyai, said he suspected foul play at the Companies and Intellectual Property Registration Office (Cipro). "I suspect that there is somebody on the inside of the system," he said after the court ordered Cipro ...
Prevalence and analysis of Pseudomonas aeruginosa in chinchillas


For the antibiotic susceptibility test, 40.9% of isolates were susceptible to gentamicin, 77.3% to ciprofloxacin, 77.3% to imipenem, and 72.7% to ceftazidime. DNA analyses confirmed that none of the isolates contained the gene encoding extended-spectrum beta-lactamases; however, ...
PFGE, Lior serotype, and antimicrobial resistance patterns among Campylobacter jejuni isolated from travelers and US military personnel with acute diarrhea in Thailand, 1998-2003


Nalidixic acid and ciprofloxacin resistance was observed in 94.9% and 93.0% of the isolates, respectively. From 2001-2003, resistance to tetracycline (81.9%), trimethoprim-sulfamethoxazole (57.9%), ampicillin (28.9%), kanamycin (5.9%), sulfisoxazole (3.9%), neomycin (2.0%), and streptomycin (0.7%) was observed. Combined PFGE analysis ...
Aradigm Announces Third Quarter 2010 Financial Results - MarketWatch


The three projects were: 1) ARD-3150 Liposomal Ciprofloxacin for the Treatment of Non-CF Bronchiectasis, 2) ARD-3100 Liposomal Ciprofloxacin for the Treatment of Cystic Fibrosis. After a determination by U.S. Department of Health and Human Services (HHS) that all three ...
Aradigm appoints new board member | TradingMarkets.com


and in particular in discussions for furthering our inhaled liposomal ciprofloxacin program," said Virgil Thompson, Aradigm's Chairman of the Board. http://www.datamonitor.com Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall ...
www.EquityTradingAlert.com: Aradigm Corporation (OTCBB: ARDM), Omni Bio Pharmaceutical, Inc. (OTCBB: OMBP), | TradingMarkets.com


We are pleased that the HHS review recognized that our inhaled liposomal ciprofloxacin programs show promise to treat areas of unmet medical needs," said ...
SGGP English Edition- Medicine prices soar


Quang Binh Pharmaceutical Company has hiked antibiotic Ciprofloxacin by VND5,000 to 50000 per box, and Terpin Codein by VND2,000 to 42000 per box. ...
Aradigm Awarded Three Therapeutic Discovery Tax Credit Grants Totaling Over $733,000 for Inhaled Liposomal Ciprofloxacin Program - MarketWatch


We are pleased that the HHS review recognized that our inhaled liposomal ciprofloxacin programs show promise to treat areas of unmet medical needs," said ...
Cipro sets up commission to streamline company regulation


The Companies and Intellectual Property Registration Office (Cipro) plans to establish a new commission to streamline and simplify company regulation in South Africa. Cipro, which is a trading entity of the Department of Trade and Industry (DTI), said that the ...
Persichilli: European-based drug giants want your money - thestar.com


Another spat erupted in 2001 when Rock was trying to make a quick purchase of 900000 doses of the antibiotic ciprofloxacin, known as Cipro, to stockpile for emergency use in case of an anthrax attack by terrorists. It appeared that Bayer AG, the company that owned ...
UPDATES: Phoney auditors forge ahead


If you want to register a company, CC or co-op quickly and without any fuss, you go to Cipro, get a CC name reservation document and clip down the street to ...
UroToday - Please Login - Etiology and sensitivity of uropathogens identified in uncomplicated lower urinary tract infections in women (ARESC Study): Implications on empiric therapy - Abstract


E. coli showed a high rate of susceptibility to phosphomycin (97.2%), nitrofurantoin (94.1%) and somewhat lower to ciprofloxacin (88.1%). ...
Medical News: IDSA: Drug Choice Changing for Cholera Treatment - in Meeting Coverage, IDSA from MedPage Today


Explain to interested patients that a single dose of azithromycin outperformed six doses of ciprofloxacin (Cipro) for the treatment of cholera. Note that clinical success -- defined as no watery stool within 48 hours of starting the drug -- was ...
The New Nation - Internet Edition


Ciprofloxacin, 500mg is usually 12-14 taka. You may get it even at a price of 2.50-3.00 taka! Is it a quality controlled drug? Several months ago I prescribed Azithromycin, 500mg, daily for several days for an infection. It did not work. Within ...
The Daily Maverick :: The Kalahari Resources hijacking - an increasingly crazy story

Business Day
This is just what it did on 27 August, when Haralambous Sferopoulos, acting under the auspices of Sacgu, and in his capacity as a Cipro agent, electronically removed siblings Daphne Mashile-Nkosi and Brian Amos Nkosi from their directorships of Kalahari Resources, replacing them with himself, ...
Aradigm Reports Successful Phase 2b Bronchiectasis Study With Inhaled Liposomal Ciprofloxacin


There is currently no drug specifically approved for the treatment of this condition in the US Ciprofloxacin is a widely prescribed antibiotic to treat infections of the lung frequently experienced by cystic fibrosis (CF) and non-cystic fibrosis bronchiectasis (BE) patients. It is often ...
Star


Majali and seven others allegedly removed Kalahari Resources' directors from the Companies and Intellectual Property Registration Office (Cipro) database in ...
Do you need a Washington, DC Cipro attorney? Contact one of our Washington, DC Cipro attorneys now.

Pages: Previous   1   2   3   4   5   6   7   8   9   10   11   ...   Next

Need A Cipro Attorney?

First Name Last Name Email Address State
Have You Suffered a Tendon Injury?

Please describe your injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Do you need a Washington, DC Cipro attorney? Contact one of our Washington, DC Cipro attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Cipro Case - Submit Your Information Below

Do you need legal assistance with your Cipro case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Cipro Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.